Brian Porter
- Rheumatology top 0.2%
- Spondyloarthritis Studies and Treatments 54
- Rheumatoid Arthritis Research and Therapies 43
- Systemic Lupus Erythematosus Research 6
- Immunology top 1%
- Psoriasis: Treatment and Pathogenesis 28
- Immune Cell Function and Interaction 8
- T-cell and B-cell Immunology 7
- Hematology top 1%
- Autoimmune and Inflammatory Disorders Research 21
- Virology top 5%
- Dermatology top 2%
-
- Infectious Diseases and Tuberculosis 7
- Co-authors
- Atul DeodharThomas R. MalekXenofon BaraliakosHanno B. RichardsJürgen BraunMats AnderssonJoachim SieperRuvie Martin
- Cited by
- RheumatologyImmunologyHematology
- Partner nations
- United StatesSwitzerlandUnited Kingdom
In The Last Decade
Brian Porter
90 papers receiving 3.6k citations
Hit Papers
Peers
Comparison fields: 5 of 114
- Rheumatology 2.0k
- Immunology 2.1k
- Hematology 999
- Virology 143
- Dermatology 186
Countries citing papers authored by Brian Porter
This map shows the geographic impact of Brian Porter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Porter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Porter more than expected).
Fields of papers citing papers by Brian Porter
This network shows the impact of papers produced by Brian Porter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Porter. The network helps show where Brian Porter may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Brian Porter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2024 | 4 | |
| 3 | 2022 | 5 | |
| 4 | 2021 | 4 | |
| 5 | 2020 | 11 | |
| 6 | 2019 | 139 | |
| 7 | 2018 | 24 | |
| 8 | 2018 | 83 | |
| 9 | Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial. | 2017 | 69 |
| 10 | 2017 | 4 | |
| 11 | 2017 | 162 | |
| 12 | 2011 | 66 | |
| 13 | 2010 | 37 | |
| 14 | 2009 | 3 | |
| 15 | 2008 | 13 | |
| 16 | 2001 | 34 | |
| 17 | 2001 | 36 | |
| 18 | 1999 | 52 | |
| 19 | 1999 | 48 | |
| 20 | 1967 | 1 |
About Brian Porter
Brian Porter is a scholar working on Rheumatology, Hematology, Immunology, Virology and Emergency Medicine, having authored 91 papers that have together received 3.6k indexed citations. Recurring topics across this work include Spondyloarthritis Studies and Treatments (54 papers), Rheumatoid Arthritis Research and Therapies (43 papers), Psoriasis: Treatment and Pathogenesis (28 papers), Autoimmune and Inflammatory Disorders Research (21 papers), Immune Cell Function and Interaction (8 papers), Infectious Diseases and Tuberculosis (7 papers), T-cell and B-cell Immunology (7 papers) and Systemic Lupus Erythematosus Research (6 papers). The work is most often cited by research in Rheumatology (2.0k citations), Immunology (2.1k citations), Hematology (999 citations), Virology (143 citations) and Dermatology (186 citations). Brian Porter has collaborated with scholars based in United States, Switzerland and United Kingdom. Frequent co-authors include Atul Deodhar, Thomas R. Malek, Xenofon Baraliakos, Hanno B. Richards, Jürgen Braun, Mats Andersson, Joachim Sieper, Ruvie Martin, Paul Emery and Dominique Baeten. Their work appears in journals such as Annals of the Rheumatic Diseases, Lara D. Veeken, AIDS, Arthritis Research & Therapy and Frontiers in Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.